期刊文献+

偏头痛患者血小板活化和血小板-白细胞相互作用:亚型的区别及曲普坦类药物的影响

Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans
下载PDF
导出
摘要 As migraine is the result of an inflammatory mechanism with serotonergic sign alling, leucocyte function, platelet function and intercellular communication be tween those cells is likely to be connected to the final pathway of the disease. We examined P- selectin expression on platelets (platelet activation) and leuc ocyte- platelet aggregate formation in 72 migraine patients during their attack - free interval and controls using a flow cytometric assay. Patients suffering from migraine without aura had a significantly increased platelet activation and leucocyte- platelet aggregation compared with the control group, unlike the mi graine patients with aura. Patients who had taken a triptan within 3 days prior to the investigation showed platelet activation values similar to the control gr oup. The variations in platelet activation patterns of migraine subgroups could indicate different pathomechanisms. Even outside an attack, migraine patients, p articularly those without aura, show an increased level of platelet activation w hich seems to be down- regulated by triptans. This mechanism may account for th e triptan- induced increases in headache frequency. The involvement of proinfla mmatory platelet- leucocyte cross- talk suggests a possible therapeutic strate gy using anti- inflammatory drugs. As migraine is the result of an inflammatory mechanism with serotonergic sign alling, leucocyte function, platelet function and intercellular communication be tween those cells is likely to be connected to the final pathway of the disease. We examined P- selectin expression on platelets (platelet activation) and leuc ocyte- platelet aggregate formation in 72 migraine patients during their attack - free interval and controls using a flow cytometric assay. Patients suffering from migraine without aura had a significantly increased platelet activation and leucocyte- platelet aggregation compared with the control group, unlike the mi graine patients with aura. Patients who had taken a triptan within 3 days prior to the investigation showed platelet activation values similar to the control gr oup. The variations in platelet activation patterns of migraine subgroups could indicate different pathomechanisms. Even outside an attack, migraine patients, p articularly those without aura, show an increased level of platelet activation w hich seems to be down- regulated by triptans. This mechanism may account for th e triptan- induced increases in headache frequency. The involvement of proinfla mmatory platelet- leucocyte cross- talk suggests a possible therapeutic strate gy using anti- inflammatory drugs.
出处 《世界核心医学期刊文摘(神经病学分册)》 2005年第10期9-9,共1页 Digest of the World Core Medical Journals:Clinical Neurology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部